Vaccinations administered during off-clinic hours at a national community pharmacy: Implications for increasing patient access and convenience

Annals of Family Medicine

Volumn 11, Issue 5, 2013, Pages 429-436

  Goad, Jeffery A ^a   Taitel, Michael S ^b   Fensterheim, Leonard E ^b   Cannon, Adam E ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Walgreen   (United States)

Author keywords

After hours care; Immunizations; Infectious diseases; Pharmacy; Vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS VACCINE; INFLUENZA VACCINE; TYPHOID PARATYPHOID VACCINE; VACCINE; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

AGE; AGED; ARTICLE; CHRONIC DISEASE; FEMALE; HEALTH CARE DELIVERY; HEALTH INSURANCE; HUMAN; IMMUNIZATIONS; INFECTIOUS DISEASES; MALE; MIDDLE AGED; PHARMACY; RETROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICS; TIME; URBAN POPULATION; VACCINATION; STATISTICS AND NUMERICAL DATA;

AFTER-HOURS CARE; IMMUNIZATIONS; INFECTIOUS DISEASES; PHARMACY; VACCINES;

AFTER-HOURS CARE; AGE FACTORS; AGED; CHRONIC DISEASE; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HERPES ZOSTER VACCINE; HUMANS; INFLUENZA VACCINES; INSURANCE, HEALTH; MALE; MIDDLE AGED; PAPILLOMAVIRUS VACCINES; PHARMACIES; RETROSPECTIVE STUDIES; SEX FACTORS; TIME FACTORS; TYPHOID-PARATYPHOID VACCINES; URBAN POPULATION; VACCINATION; VIRAL HEPATITIS VACCINES; YELLOW FEVER VACCINE;

EID: 84883823822     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.1542     Document Type: Article

References (35)

1. National Foundation for Infectious Diseases. Facts about adult immunization. August 2009. http://www.nfid.org/publications/factsheets/ adultfact.pdf. Accessed May 29, 2012.
2. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among children aged 19-35 months-United States, 2009. MMWR Morb Mortal Wkly Rep. 2010; 59(36):1171-1177.
3. Centers for Disease Control and Prevention. Adult vaccination coverage-United States, 2010. MMWR Morb Mortal Wkly Rep. 2012; 61(4):66-72.
4. Centers for Disease Control and Prevention. Estimates of deaths associated with seasonal influenza-United States, 1976-2007. MMWR Morb Mortal Wkly Rep. 2010;59(33):1057-1062.
5. Centers for Disease Control and Prevention. Final state-level influenza vaccination coverage estimates for the 2010-11 season-United States, National Immunization Survey and Behavioral Risk Factor Surveillance System, August 2010 through May 2011. 2011. http://www.cdc.gov/flu/professionals/vaccination/ coverage_1011estimates.htm. Accessed May 28, 2012.
6. Freed GL, Clark SJ, Cowan AE, Coleman MS. Primary care physician perspectives on providing adult vaccines. Vaccine. 2011;29(9): 1850-1854.
7. Postema AS, Breiman RF; National Vaccine Advisory Committee. Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation. MMWR Recomm Rep. 2000;49(RR-1):1-13.
8. Centers for Disease Control and Prevention. Place of influenza vaccination among adults-United States, 2010-11 influenza season. MMWR Morb Mortal Wkly Rep. 2011;60(23):781-785.
9. Crawford ND, Blaney S, Amesty S, et al. Individual-and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: pharmacists' role in reducing racial/ethnic disparities in influenza vaccinations in New York City. J Urban Health. 2011;88(1):176-185.
10. Hogue MD, Grabenstein JD, Foster SL, Rothholz MC. Pharmacist involvement with immunizations: a decade of professional advancement. J Am Pharm Assoc (2003). 2006;46(2):168-179; quiz 179-182.
11. Uscher-Pines L, Maurer J, Kellerman A, Harris KM. Healthy young and middle age adults: what will it take to vaccinate them for influenza? Vaccine. 2010;28(46):7420-7422.
12. Westrick SC. Pharmacy characteristics, vaccination service characteristics, and service expansion: an analysis of sustainers and new adopters. J Am Pharm Assoc (2003). 2010;50(1):52-61.
13. Murphy PA, Frazee SG, Cantlin JP, Cohen E, Rosan JR, Harshburger DE. Pharmacy provision of influenza vaccinations in medically underserved communities. J Am Pharm Assoc (2003). 2012;52(1):67-70.
14. Francis M, Hinchliffe A. Vaccination Services Through Community Pharmacy: A Literature Review. Cardiff, Wales, United Kingdom: Public Health Wales; 2010.
15. Schoen C, Osborn R, Huynh PT, Doty M, Peugh J, Zapert K. On the front lines of care: primary care doctors' office systems, experiences, and views in seven countries. Health Aff (Millwood). 2006;25(6):w555-w571.
16. US Office of Personal Management. Operating Status & Schedules. 2011. http://www.opm.gov/operating_status_schedules/fedhol/2011. asp. Accessed Nov 21, 2012.
17. Medi-Span. Drug Indications Database: Documentation Manual. Indianapolis, IN: Wolters Kluwer Health, Inc; 2003.
18. Morrill RCJ, Hart LG. Metropolitan, urban, and rural commuting areas: toward a better depiction of the U.S. settlement system. Urban Geogr. 1999;20(8):727-748.
19. Skelton JB. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting. J Am Pharm Assoc (2003). Nov-Dec 2011;51(6):704-712.
20. Advisory Committee on Immunization Practices. Recommended immunization schedules for persons aged 0 through 18 years-United States, 2012. MMWR Morb Mortal Wkly Rep. 2012;61(5):1-4. Corrected in MMWR Morb Mortal Wkly Rep. 2012 2;61(8):147. (Note: Dosage error in article text).
21. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2012. MMWR Morb Mortal Wkly Rep. 2012;61(4)1-7.
22. United States Department of Labor Bureau of Labor Statistics. Workers on Flexible and Shift Schedules in 2004, Summary. 2005. http://www.bls.gov/news.release/flex.nr0.htm. Accessed Nov 15, 2012.
23. Nichol KL, Mallon KP, Mendelman pm. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. Vaccine. 2003;21(17-18):2207-2217.
24. Eames KTD, Brooks-Pollock E, Paolotti D, Perosa M, Gioannini C, Edmunds WJ. Rapid assessment of influenza vaccine effectiveness: analysis of an Internet-based cohort. Epidemiol Infect. 2012;140 (7):1309-1315.
25. Lynch MF, Blanton EM, Bulens S, et al. Typhoid fever in the United States, 1999-2006. JAMA. 2009;302(8):859-865.
26. Hamer DH, Connor BA. Travel health knowledge, attitudes and practices among United States travelers. J Travel Med. 2004;11(1):23-26.
27. Durham MJ, Goad JA, Neinstein LS, Lou M. A comparison of pharmacist travel-health specialists' versus primary care providers' recommendations for travel-related medications, vaccinations, and patient compliance in a college health setting. J Travel Med. 2011;18(1):20-25.
28. Healthy People 2020. US Department of Health and Human Services. Office of Disease Prevention and Health Promotion. http:// www.healthypeople.gov/2020/default.aspx. Accessed May 30, 2012.
29. Ndiaye SM, Madhavan S, Washington ML, et al. The use of pharmacy immunization services in rural communities. Public Health. 2003;117(2):88-97.
30. Taitel M, Cohen E, Duncan I, Pegus C. Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations. Vaccine. 2011;29(45):8073-8076.
31. Steyer TE, Ragucci KR, Pearson WS, Mainous AG III. The role of pharmacists in the delivery of influenza vaccinations. Vaccine. 2004; 22(8):1001-1006.
32. Taitel MS, Fensterheim LE, Cohen ES, Cannon AE. Improving pneumococcal and herpes zoster vaccination uptake: expanding pharmacist privileges. Am J Manag Care. 2013;19(9):e309-e313.
33. Mehrotra A, Lave JR. Visits to retail clinics grew fourfold from 2007 to 2009, although their share of overall outpatient visits remains low. Health Aff (Millwood). 2012;31(9):2123-2129.
34. Grabenstein JD, Guess HA, Hartzema AG. People vaccinated by pharmacists: descriptive epidemiology. J Am Pharm Assoc (2003). 2001;41(1):46-52.
35. Pilisuk T, Goad J, Backer H. Vaccination delivery by chain pharmacies in California: results of a 2007 survey. J Am Pharm Assoc (2003). 2010;50(2):134-139.